Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis Webinar

Webinar
2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis Webinar

The 2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis webinar provides an overview of the guidelines development process, key changes in recommendations, and the evidence supporting the changes.

Author:

Global Tuberculosis Institute at Rutgers The State University of New Jersey, Curry International TB Center, Heartland National Tuberculosis Center, Southeastern National Tuberculosis Center, Mayo Clinic Center for Tuberculosis, Curry International TB Center, SNTC

Topic:

Treatment- TB Disease

View Webpage

Related Materials

Practical Implementation of the 2016 ATS/CDC/IDSA Treatment of Drug Susceptible Tuberculosis Guidelines: Caveats and Controversies

This webinar provides an overview of the 2016 ATS/CDC/IDSA Treatment of Drug Susceptible Tuberculosis Guidelines and practical tips for implementation. Case studies are also presented.

Webinar

Treatment of Drug-Resistant Tuberculosis An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly sponsored this new practice guideline on the treatment of drug-resistant tuberculosis (DR-TB). The document includes recommendations on the treatment of multidrug-resistant TB (MDR-TB) as well as isoniazid-resistant but rifampin-susceptible TB.

Guideline

Guidelines for Treatment of Drug-Susceptible Tuberculosis and Patient Care (2017 update)

These guidelines contain policy recommendations on priority areas in the treatment of drug-susceptible TB and patient care.

Guideline

Global resources for the prevention,
management, and elimination of TB.